ClearanceBrief
Recall Z-1597-2021 ยท MUJ System, Planning, Radiation Therapy Treatment

RAYSEARCH LABORATORIES AB

RayStation 4.5, 4.7, 4.9, 5, 6, 7, 8A, 8B, 9A, 9B, 10A, 10B, RayPlan 1, 2, 7, 8A, 8B, 9A, 10A, 10B including some of the Service Packs. Standalone software treatment planning system

DateFeb 22, 2021
StatusTerminated
ReasonFor some LINAC types, merging clinical beams with beams of approximate dose may lead to the approximate dose erroneously labeled as clinical dose. Merge beams can be used manually, in scripting, or as part of the Automated breast planning feature. In some cases, when merging two beams where the first beam has clinical dose and the second beam has approximate dose, the dose of the resulting beam will be labeled as Clinical, although dose for some of the beam segments is still calculated with the SVD dose engine and it should be labeled Approximate: Mixed dose. The difference between approximate
Root causeSoftware design
ActionRaySearch issued Field Safety Notice, Medical Device Correction #74977 letter on 22 February 2021 via Email. Letter states reason for recall, health risk and action to take: ACTIONS TO BE TAKEN BY THE USER " Manual Merge beams in the 3D-CRT module Scenario: When merging a beam B1 with other beams (e.g., B2 and B3) in the 3D-CRT module. Action: If the target beam B1 has a clinical dose before the merge, make sure that all the beamsto be merged (B2 and B3) also have a clinical dose computed with the same dose engine. " Scripting when using the action MergeBeamSegments Scenario: When running a sc
Quantity116 units
DistributionUS Nationwide distribution.
FDA recordOpen on fda.gov

510(k) clearances named in this recall

K200569RayStation
RaySearch Laboratories AB (PUBL), Sep 24, 2020